Mar. 18 at 9:23 PM
$TNXP 🚀🚀🚀
https://ir.stockpr.com/tonixpharma/sec-filings-email/content/0001999371-26-006235/form4-lederman_031826.html
Tonix Pharmaceuticals (Form 4 Filing, March 18, 2026)
Tonix Pharmaceuticals Holding Corp. disclosed a Form 4 insider transaction reporting that Seth Lederman, M.D., President, CEO, and Chairman, purchased 15,000 shares of common stock on March 18, 2026 at a price of
$14.89 per share.
The transaction represents an approximate
$223,350 open-market purchase and was reported as an indirect holding through Dr. Lederman’s IRA account. Following the transaction, the IRA account held 15,001 shares.
The filing also shows Dr. Lederman’s reported post-transaction ownership as:
15,001 shares held indirectly through an IRA account
4,005 shares held directly
1 share held indirectly through Lederman & Co.
This brings his total reported ownership in the filing to approximately 19,007 shares of common stock. No derivative securities were reported in the filing.🚀🚀🚀🚀
